15-27926148-T-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000275.3(OCA2):​c.2058A>C​(p.Ala686Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0104 in 1,614,022 control chromosomes in the GnomAD database, including 1,439 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A686A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.053 ( 746 hom., cov: 33)
Exomes 𝑓: 0.0059 ( 693 hom. )

Consequence

OCA2
NM_000275.3 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.868

Publications

3 publications found
Variant links:
Genes affected
OCA2 (HGNC:8101): (OCA2 melanosomal transmembrane protein) This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
OCA2 Gene-Disease associations (from GenCC):
  • oculocutaneous albinism type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000275.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 15-27926148-T-G is Benign according to our data. Variant chr15-27926148-T-G is described in ClinVar as Benign. ClinVar VariationId is 255727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.868 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.183 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000275.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OCA2
NM_000275.3
MANE Select
c.2058A>Cp.Ala686Ala
synonymous
Exon 19 of 24NP_000266.2Q04671-1
OCA2
NM_001300984.2
c.1986A>Cp.Ala662Ala
synonymous
Exon 18 of 23NP_001287913.1Q04671-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OCA2
ENST00000354638.8
TSL:1 MANE Select
c.2058A>Cp.Ala686Ala
synonymous
Exon 19 of 24ENSP00000346659.3Q04671-1
OCA2
ENST00000353809.9
TSL:1
c.1986A>Cp.Ala662Ala
synonymous
Exon 18 of 23ENSP00000261276.8Q04671-2
OCA2
ENST00000910120.1
c.2058A>Cp.Ala686Ala
synonymous
Exon 19 of 26ENSP00000580179.1

Frequencies

GnomAD3 genomes
AF:
0.0534
AC:
8125
AN:
152114
Hom.:
745
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.186
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0159
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00165
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00121
Gnomad OTH
AF:
0.0378
GnomAD2 exomes
AF:
0.0145
AC:
3634
AN:
251184
AF XY:
0.0106
show subpopulations
Gnomad AFR exome
AF:
0.192
Gnomad AMR exome
AF:
0.00784
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.000381
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00129
Gnomad OTH exome
AF:
0.00799
GnomAD4 exome
AF:
0.00593
AC:
8663
AN:
1461790
Hom.:
693
Cov.:
32
AF XY:
0.00520
AC XY:
3782
AN XY:
727196
show subpopulations
African (AFR)
AF:
0.196
AC:
6548
AN:
33474
American (AMR)
AF:
0.00903
AC:
404
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00122
AC:
32
AN:
26130
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39676
South Asian (SAS)
AF:
0.00118
AC:
102
AN:
86258
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53416
Middle Eastern (MID)
AF:
0.00971
AC:
56
AN:
5766
European-Non Finnish (NFE)
AF:
0.000662
AC:
736
AN:
1111958
Other (OTH)
AF:
0.0129
AC:
781
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
374
747
1121
1494
1868
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
202
404
606
808
1010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0535
AC:
8142
AN:
152232
Hom.:
746
Cov.:
33
AF XY:
0.0514
AC XY:
3823
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.186
AC:
7727
AN:
41510
American (AMR)
AF:
0.0159
AC:
243
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00121
AC:
82
AN:
68008
Other (OTH)
AF:
0.0374
AC:
79
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
353
707
1060
1414
1767
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0201
Hom.:
178
Bravo
AF:
0.0606
EpiCase
AF:
0.00174
EpiControl
AF:
0.00184

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
not specified (1)
-
-
1
Tyrosinase-positive oculocutaneous albinism (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.68
DANN
Benign
0.48
PhyloP100
-0.87
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1800416;
hg19: chr15-28171294;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.